Partner Content Partner Content Sports Medicine Market will register 6% CAGR from 2019 to 20... Sports Medicine Market will exceed USD 9 bn by 2025
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
